Sysco Interest Paid decreased by 1.7% to $170.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 29.8%, from $131.00M to $170.00M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows a downward trend with a -8.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $490.76M | $225.03M | $33.41M | $198.56M | $41.00M | $84.01M | $160.52M | $98.87M | $167.60M | $94.00M | $172.00M | $110.00M | $181.00M | $144.00M | $178.00M | $131.00M | $176.00M | $178.00M | $173.00M | $170.00M |
| QoQ Change | — | -54.1% | -85.2% | +494.4% | -79.3% | +104.9% | +91.1% | -38.4% | +69.5% | -43.9% | +83.0% | -36.0% | +64.5% | -20.4% | +23.6% | -26.4% | +34.4% | +1.1% | -2.8% | -1.7% |
| YoY Change | — | — | — | — | -91.6% | -62.7% | +380.5% | -50.2% | +308.7% | +11.9% | +7.2% | +11.3% | +8.0% | +53.2% | +3.5% | +19.1% | -2.8% | +23.6% | -2.8% | +29.8% |